Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UralDial is a Russian healthcare company specializing in the production of high-quality consumables for hemodialysis. Based in Yekaterinburg, the company manufactures a comprehensive range of acid and bicarbonate concentrates in both liquid and dry powder forms, which are essential for renal replacement therapy. UralDial serves a critical role in the Russian medical supply chain, providing dialysis centers and hospitals with the necessary components to treat patients with chronic kidney disease and end-stage renal failure. In addition to dialysis concentrates, the company produces specialized disinfectants designed for the maintenance and sterilization of hemodialysis equipment. The company's products are developed to meet international safety standards, ensuring reliable performance in clinical settings. UralDial is recognized for its contribution to the localization of medical production in the Ural region, reducing dependency on imported dialysis supplies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UralDial.